Track 21: Oral Cancers – Advancing Early Detection, Diagnosis, and Treatment
.png)
Oral cancer remains one of the most significant global health challenges, accounting for hundreds of thousands of new cases each year. Despite remarkable advances in diagnosis and treatment, delayed detection continues to result in poor patient outcomes. Research in oral oncology is rapidly evolving, focusing on early diagnosis, precision medicine, novel therapeutic approaches, and improved patient survival.
Track 21: Oral Cancers at the 6th International Conference on Advanced Dentistry,
Oral Health & Exhibition provides a dedicated platform
for dentists, oral surgeons, oncologists, pathologists, researchers,
academicians, and healthcare professionals to present innovative research,
clinical experiences, and emerging technologies that are shaping the future of
oral cancer prevention and management.
Why Oral Cancer Research
Matters
Oral cancers, particularly oral squamous cell
carcinoma (OSCC), represent a major public health concern worldwide. Early
diagnosis dramatically improves treatment success and survival rates, making
routine screening, risk assessment, and patient education essential
responsibilities for dental professionals.
Advancements in molecular biology, imaging
technologies, artificial intelligence, biomarkers, immunotherapy, and
personalized treatment strategies are transforming the management of oral
malignancies while improving patients' quality of life.
Topics Covered Under
Track 21
Researchers are invited to submit abstracts
covering, but not limited to:
- Oral Squamous Cell Carcinoma
(OSCC)
- Precancerous Oral
Lesions
- Oral Potentially
Malignant Disorders (OPMDs)
- Leukoplakia and
Erythroplakia
- Oral Cancer Screening
and Early Detection
- Oral Cytology and
Biopsy Techniques
- Molecular Biomarkers
in Oral Cancer
- HPV-Associated Oral
Cancers
- Tobacco, Alcohol, and
Lifestyle Risk Factors
- Oral Cancer
Prevention Programs
- AI Applications in
Oral Cancer Diagnosis
- Imaging Technologies
for Early Detection
- Surgical Oncology
- Reconstructive
Surgery Following Oral Cancer
- Radiotherapy and Chemotherapy
- Immunotherapy and
Targeted Therapy
- Precision Oncology
- Salivary Diagnostics
- Oral Pathology and
Histopathology
- Cancer Survivorship
and Rehabilitation
- Quality of Life After
Oral Cancer Treatment
- Palliative Care in
Oral Oncology
- Clinical Trials and
Translational Research
Who Should
Participate?
This scientific track welcomes:
- Dentists
- Oral and
Maxillofacial Surgeons
- Oral Medicine
Specialists
- Oral Pathologists
- Oncologists
- Head and Neck
Surgeons
- Dental Researchers
- University
Professors
- Postgraduate
Students
- Clinical Scientists
- Public Health
Professionals
- Healthcare
Innovators
Why Present Your
Research?
Presenting your work at DentalUCG offers
numerous professional benefits:
- Share your research with an
international audience.
- Receive valuable feedback
from leading experts.
- Build collaborations with
researchers and clinicians worldwide.
- Increase the visibility and
impact of your research.
- Learn about emerging
diagnostic and therapeutic technologies.
- Network with global dental
and oncology professionals.
- Contribute to advancing oral
cancer prevention and patient care.
Shape the Future of Oral Oncology
As technology and biomedical research continue
to revolutionize oral healthcare, collaboration among clinicians, scientists,
and educators has never been more important. DentalUCG aims to
bring together global experts committed to reducing the burden of oral cancer
through innovation, education, and multidisciplinary research.
Whether your work focuses on early diagnosis,
molecular research, clinical treatment, prevention, rehabilitation, or public
health initiatives, Track 21 provides an excellent opportunity to share your
findings and contribute to the future of oral oncology.
Submit Your Abstract
Today
Abstract Submission Deadline:
July 31st, 2026
Submit Your
Abstract: https://dental.ucgconferences.com/submit-abstract
WhatsApp: https://wa.me/+971551792927
Join DentalUCG2027 in Kuala Lumpur, Malaysia, on February 04–05, 2027, and become part of an international scientific forum dedicated to advancing research, innovation, and excellence in oral cancer diagnosis, prevention, and treatment.
Comments
Post a Comment